Anakinra prophylaxis in pts with RRMM receiving orvacabtagene autoleucel (orva-cel) International Myeloma Foundation 3:03 3 years ago 117 Далее Скачать
Retrospective study of anakinra to manage ICANS in patients treated with CAR-T therapy VJHemOnc – Video Journal of Hematology & HemOnc 2:56 1 year ago 146 Далее Скачать
Characteristics of neurotoxicity associated with ide-cel in pts with RRMM in phase II KarMMa International Myeloma Foundation 3:41 3 years ago 160 Далее Скачать
Elranatamab in Combination with Daratumumab for Pts with RRMM: Phase 3 MagnetisMM-5 International Myeloma Foundation 9:07 1 year ago 547 Далее Скачать
KarMMa-4: Idecabtagene vicleucel in high-risk newly diagnosed multiple myeloma International Myeloma Foundation 2:19 3 years ago 338 Далее Скачать
Elranatamab: Extended Follow-up & Biweekly Admin for RRMM | MagnetisMM-3 Study | ASCO 2023 International Myeloma Foundation 6:54 1 year ago 705 Далее Скачать
Efficacy and Safety of Elranatamab in Pts with Relapsed/Refractory Multiple Myeloma: MagnetisMM-3 International Myeloma Foundation 9:14 1 year ago 773 Далее Скачать
Safety and efficacy of elranatamab in RRMM & prior BCMA therapies: Analysis from MagnetisMM studies International Myeloma Foundation 7:04 1 year ago 237 Далее Скачать
Effects of refractory status to lenalidomide of XVd versus Vd in pts with previously treated MM International Myeloma Foundation 6:30 3 years ago 171 Далее Скачать
Evaluating the safety and efficacy of elranatamab in multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 4:17 1 year ago 269 Далее Скачать
The value of teclistamab in R/R myeloma & strategies to mitigate toxicities VJHemOnc – Video Journal of Hematology & HemOnc 1:45 1 year ago 239 Далее Скачать
Further Investigation of Veliparib Underway for Glioblastoma Targeted Oncology 0:58 4 years ago 146 Далее Скачать
Correlation between SARS-CoV-2 RNA Vaccination in Myeloma Pts & Anti-CD38 & BCMA-Targeted Treatment International Myeloma Foundation 9:12 2 years ago 723 Далее Скачать
SURPASS: evaluating the next-generation of SPEAR T-cell therapy VJRegenMed 1:22 3 years ago 85 Далее Скачать
EVOLVE: Orva-cel in RRMM VJHemOnc – Video Journal of Hematology & HemOnc 7:26 4 years ago 161 Далее Скачать
Safety and Efficacy of Multiantigen-Targeted T Cells for Multiple Myeloma International Myeloma Foundation 3:31 6 years ago 329 Далее Скачать
What immunotherapies are used in myeloma? Can IMiDs be considered a form of immunotherapy? #myeloma HealthTree University for Multiple Myeloma 2:31 4 years ago 220 Далее Скачать
Perspectives on the treatment of patients with R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:11 2 years ago 163 Далее Скачать
Idecabtagene vicleucel for R/R multiple myeloma with renal impairment VJHemOnc – Video Journal of Hematology & HemOnc 2:00 1 year ago 126 Далее Скачать
